Publication: C57-01 the effect of PM2.5 And SARS-CoV-2 on ACE2 and TMPSS2expression and anti-viral response in Calu-3 airway epithelial cells
Program
KU Authors
Co-Authors
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
eng
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Rationale Although studies have shown that air pollutants affect SARS-CoV-2 infection severity, the underlying mechanisms remain unclear. Our aim was to investigate the impacts of particulate matter less than 2.5 um (PM2.5) and SARS-CoV-2 on inflammatory changes and inflammasomal responses of Calu-3 cells. Methods Calu-3 airway epithelial cells were exposed to PM2.5 at concentrations of 10, 50, and 100 ug/mL, and to SARS-CoV-2 at an MOI of 0.01 for 24 hours. Cell viability was evaluated by the MTT assay, and epithelial barrier integrity was assessed through immunofluorescence staining of Zonula Occludens-1. The mRNA expression of viral entry genes—angiotensin-converting enzyme (ACE)2 and transmembrane protease serine (TMPRSS)2—as well as inflammatory and inflammasome-related genes including interleukin (IL)-8, IL-6, nuclear factor (NF)-kB p65 (RELA), JNK, c-JUN, Caspase-1 (CASP1), IL-1B, NLRP3, and interferon gamma (IFNg) was analyzed using qRT-PCR. Intracellular viral spike protein levels and RNA-dependent RNA polymerase (RdRP) expression were examined by immunofluorescence staining and qRT-PCR, respectively, while the release inflammatory cytokines were analyzed by ELISA. Results Higher concentrations of 100ug/mL PM2.5 reduced Calu-3 cell viability (p = 0.02) and damaged epithelial barrier integrity. PM2.5 (50ug/ml) increased mRNA expression for ACE2 and TMPRSS2 (p Conclusions Our results show that PM2.5 impair epithelial integrity and cell viability, raises mRNA levels of ACE2 and TMPRSS2, and causes inflammation in Calu-3 cells exposed to SARS-CoV-2. These results suggest that PM2.5 may facilitate SARS-CoV-2 entry into airway epithelial cells, and that both PM2.5 and SARS-CoV-2 can deteriorate the host cell’s inflammatory and antiviral defenses. This abstract is funded by: Turkish Thoracic Society
Source
Publisher
Oxford University Press
Subject
Critical care medicine, Respiratory system
Citation
Has Part
Source
American Journal of Respiratory and Critical Care Medicine
Book Series Title
Edition
DOI
10.1093/ajrccm/aamag162.5273
item.page.datauri
Link
Rights
N/A
Copyrights Note
Creative Commons license
Except where otherwised noted, this item's license is described as N/A
